Insider trade

CEO sold ~$175K of HIMS shares in the open market

Traded Oct 16, 2025 · Filed Oct 20, 2025

Why it stands out

The CEO of Hims & Hers Health sold $175K of Hims & Hers Health shares. The filing says it was made under a pre-arranged trading plan.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

CEO$100K–$500KPre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$174,924

Shares × reported transaction price

Timing vs results

73 days after results of Aug 4, 2025, 18 days before results of Nov 3, 2025

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	−4.5%	+2.4%	−6.9%
30 days	−31.9%	−2.8%	−29.1%
90 days	−38.3%	+0.9%	−39.2%
180 days	−37.2%	+5.6%	−42.8%

Past results only. Not a forecast.

The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $62.50 - $62.87. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.